🇺🇸 FDA
Patent

US 12161621

Methods for fructokinase mediation of alcohol craving and alcohol induced liver disease

granted A61KA61K31/37A61K31/713

Quick answer

US patent 12161621 (Methods for fructokinase mediation of alcohol craving and alcohol induced liver disease) held by The Regents of the University of Colorado expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado
Grant date
Tue Dec 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/37, A61K31/713, A61K36/00, A61K45/06